Oxipit ChestLink

by Oxipit (part of Sectra group)  · Based in Lithuania → — The world's first autonomous radiology AI
Emergency Medicine Pulmonology Radiology

Regulatory Status Disclosed

Overview

Oxipit ChestLink is an AI-powered medical imaging tool designed for autonomous reporting of normal chest X-ray studies. It is intended for use by radiologists and healthcare providers in various care settings, including primary care and outpatient clinics, to manage high volumes of chest X-rays.

  • What it does: ChestLink analyzes chest X-ray images to identify studies with no abnormalities. When the AI is highly confident that a study is normal, it autonomously generates a final patient report without requiring radiologist intervention. If the AI cannot confidently rule out abnormalities, the study is routed for radiologist review.
  • Who it is for: This tool is primarily for radiologists and radiology departments seeking to optimize workflow and reduce the reporting burden of routine, normal chest X-rays.
  • How it fits a clinical workflow: ChestLink integrates into existing PACS and RIS environments. It can operate in a supervised mode, where preliminary reports are monitored, or in an autonomous prospective reporting mode for high-confidence normal cases. Deployment typically begins with a retrospective analysis of a facility’s chest X-ray data to estimate the proportion of studies that can be autonomously reported.
  • Notable capabilities: ChestLink is capable of identifying normal chest X-ray studies with high sensitivity. It aims to automate a portion of the daily chest X-ray workload, allowing radiologists to focus on more complex cases. The software is certified as a CE Class IIb medical device.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Autonomous healthy patient report generation
  • 99.9% sensitivity in detecting normal chest X-rays
  • Automates up to 40% of radiologists' workflow for healthy chest X-rays
  • Abnormality detection and highlighting in chest X-rays
  • Triage functionality for prioritizing X-rays
  • Integration in standard reading environment (PACS) and RIS (Radiological Information System)
  • Real-time reporting data and periodic reporting summaries via analytics dashboard
  • Reduces radiologist workload
  • Enhances diagnostic accuracy
  • Supports confident decision-making

Use Cases

  • Automating healthy chest X-ray reporting
  • Reducing radiologist workload for routine cases
  • Improving efficiency in radiology workflows
  • Prioritizing complex cases for radiologists
  • Real-time quality assurance for chest X-ray reports
  • Prophylactic (occupational) health checks

What Physicians Need to Know

Evidence Base
ChestLink is the first fully autonomous AI medical imaging product with a CE mark (Class IIb medical device certification). It was trained on a dataset of over 500,000 images. The algorithms support 75 different pathologies.
Clinical Validation Studies
ChestLink has undergone multiple clinical validation studies. A study analyzing 10,000 chest X-rays from Finnish primary care patients found that ChestLink identified normal studies with 99.8% sensitivity and 36.4% specificity, with a minimal number of false negatives and no critical findings missed. Another study published in Radiology in March 2023 highlighted the tool's high sensitivity for various chest diseases, stating no major mistakes were found in their database. A UK study on 140,000 scans showed a discordance rate of only 4%, dropping to 1% after consultant radiologist review, indicating ChestLink missed only 1% of cases that should have been deemed abnormal. In a retrospective and prospective validation involving approximately 20,000 chest radiographs, ChestLink demonstrated the capacity to autonomously report 15u201320% of studies as normal with 99.9% sensitivity.
Alert Fatigue Management
ChestLink is designed to reduce radiologist workload by autonomously reporting on chest X-rays with no abnormalities, allowing radiologists to focus on cases with pathologies. It can automate up to 30-40% of daily X-ray workflow. In cases where ChestLink cannot confidently rule out actionable radiological findings, the study is directed to a radiologist for review, effectively managing alerts by only escalating potentially abnormal cases.
Override Rate Data
In a UK study of 140,000 scans, the initial discordance rate between ChestLink and radiologists was 4%, which dropped to 1% after a consultant radiologist's review. This suggests a low override rate for ChestLink's 'normal' classifications.
Differential Diagnosis Support
While ChestLink's primary function is autonomous reporting of *normal* chest X-rays, its companion product, ChestEye, detects 75 common findings in chest X-rays, localizes them, and produces preliminary reports. This suggests that the broader Oxipit CXR Suite offers comprehensive diagnostic support, with ChestLink handling the 'no abnormality' cases and ChestEye assisting with the identification of specific pathologies.
Clinical Workflow Integration
ChestLink integrates with standard reading environments (PACS) and Radiological Information Systems (RIS). It can be deployed as a cloud-based, hybrid, or on-premise solution. The analysis is triggered automatically after image acquisition, with processing times ranging from 10-60 seconds. Deployment typically follows a three-stage framework: retrospective analysis, supervised operations, and then autonomous reporting. The system provides an analytics dashboard with real-time updates and daily summaries for transparency and traceability of application decisions.
Decision Audit Trail
ChestLink provides an analytics dashboard with real-time reporting data and periodic reporting summaries for full transparency and traceability of application actions and decisions.
Physician Tip

ChestLink is particularly valuable for managing high volumes of chest X-rays, especially in primary care settings where a significant percentage of studies are normal. By autonomously reporting on these 'no abnormality' cases, it frees up radiologist time to focus on more complex or urgent studies, potentially reducing workload and improving turnaround times. Physicians should be aware that ChestLink is designed for autonomous reporting of *normal* studies; any suspicious findings are flagged for radiologist review. The system's high sensitivity for detecting abnormalities ensures that critical findings are not missed.

ChestLink integrates with existing Healthcare IT systems, including PACS and RIS, and can be accessed via AI marketplaces or distribution platforms. It supports DICOM SR or HL7 messaging for output. Oxipit has partnerships with platforms like deepcOS and Sectra, facilitating seamless integration into various clinical environments.

Details

Category Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Pending AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Pulmonology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Oxipit ChestLink

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Oxipit ChestLink.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Oxipit ChestLink is designed for seamless integration with your current Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR). It typically operates in the background, analyzing chest X-rays as they are acquired and pushing its findings directly into your existing reporting interface or flagging studies for review within your PACS.
ChestLink has undergone rigorous validation and is backed by clinical studies demonstrating its high accuracy in detecting various pathologies on chest X-rays. These studies often highlight its performance in identifying critical findings, reducing false negatives, and improving overall diagnostic efficiency.
Oxipit ChestLink holds relevant regulatory approvals, such as CE Mark in Europe and FDA clearance in the United States, ensuring its compliance with medical device regulations. It adheres to strict data privacy and security standards, including GDPR and HIPAA, to protect patient information.
ChestLink is designed to prioritize and highlight emergent or critical findings on chest X-rays. It can be configured to trigger immediate alerts or notifications within your PACS or EMR, ensuring that radiologists are promptly informed of potentially life-threatening conditions for urgent review.
While highly accurate, ChestLink, like any AI tool, has limitations. It's crucial to understand that it is a decision support tool and not a replacement for a radiologist's interpretation. Certain subtle findings, rare pathologies, or complex cases may still require careful human review, and the system's performance can vary depending on image quality and specific clinical context.
Oxipit offers various pricing models for ChestLink, which can include subscription-based licenses or per-study fees, depending on the volume and specific integration needs of your institution. The cost-effectiveness often stems from improved efficiency, reduced turnaround times, and potentially decreased rates of missed findings compared to traditional methods or other AI alternatives.
Yes, there are other AI solutions available for chest X-ray analysis. ChestLink differentiates itself through its high diagnostic accuracy, comprehensive range of detected pathologies, seamless integration capabilities, and robust clinical validation. Its specific algorithms and user interface may also offer unique advantages in certain clinical settings.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-09-30 | First Added: 2026-09-30
AI Tool Finder
AI-powered search. Results may not be comprehensive.